Lenalidomide regulates the CCL21/CCR7/ERK1/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 199, doi. 10.32604/or.2024.050036
- By:
- Publication type:
- Article
Works matching IS 09650407 AND DT 2025 AND VI 33 AND IP 1
Results: 7
1
2
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 57, doi. 10.32604/or.2024.049054
- By:
- Publication type:
- Article
3
STIL enhances the development of lung adenocarcinoma by regulating the glycolysis pathway.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 123, doi. 10.32604/or.2024.048562
- By:
- Publication type:
- Article
4
Long noncoding RNA LINC01106 promotes lung adenocarcinoma progression via upregulation of autophagy.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 171, doi. 10.32604/or.2024.047626
- By:
- Publication type:
- Article
5
TMED3 promotes prostate cancer via FOXO1a and FOXO3a phosphorylation.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 161, doi. 10.32604/or.2024.048054
- By:
- Publication type:
- Article
6
Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 213, doi. 10.32604/or.2024.046895
- By:
- Publication type:
- Article
7
lncRNA SNHG4 enhanced gastric cancer progression by modulating miR-409-3p/CREB1 axis.
- Published in:
- Oncology Research, 2025, v. 33, n. 1, p. 185, doi. 10.32604/or.2024.042281
- By:
- Publication type:
- Article